Acadian Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-933,102
| Closed | -$8.96M | – | 1859 |
|
|
2024
Q4 | $8.96M | Buy |
933,102
+102,061
| +12% | +$979K | 0.03% | 386 |
|
|
2024
Q3 | $2.38M | Buy |
831,041
+431,202
| +108% | +$1.23M | 0.01% | 696 |
|
|
2024
Q2 | $1.17M | Buy |
399,839
+34,321
| +9% | +$100K | ﹤0.01% | 946 |
|
|
2024
Q1 | $1.17M | Sell |
365,518
-136,201
| -27% | -$434K | ﹤0.01% | 803 |
|
|
2023
Q4 | $1.69M | Sell |
501,719
-350,120
| -41% | -$1.18M | 0.01% | 716 |
|
|
2023
Q3 | $2.03M | Sell |
851,839
-259,533
| -23% | -$617K | 0.01% | 690 |
|
|
2023
Q2 | $1.95M | Buy |
1,111,372
+99,989
| +10% | +$176K | 0.01% | 698 |
|
|
2023
Q1 | $3.12M | Buy |
1,011,383
+811,819
| +407% | +$2.5M | 0.01% | 591 |
|
|
2022
Q4 | $1.06M | Buy |
+199,564
| New | +$1.06M | 0.01% | 829 |
|
|
2022
Q3 | – | Sell |
-12,099
| Closed | -$31K | – | 1890 |
|
|
2022
Q2 | $31K | Buy |
+12,099
| New | +$31K | ﹤0.01% | 1569 |
|